Insider · CIK 0001604541

Went Gregory T

Reports to the SEC for 1 company · EMERYVILLE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001604541

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-04-08	Adamas Pharmaceuticals IncA Award	Director, Chief Executive Officer	AAward	+56.3K sh	—	—	232,541
2019-04-08	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+113K sh	—	—	112,500
2019-03-20	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−6,319 sh	$7.99	−$50.5K	176,291
2018-11-07	Adamas Pharmaceuticals IncP Purchase	Director, Chief Executive Officer	PPurchase	+3,850 sh	$12.98	+$50K	199,242
2018-03-21	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−4,541 sh	$25.75	−$117K	182,610
2018-03-06	Adamas Pharmaceuticals IncA Award	Director, Chief Executive Officer	AAward	+20.6K sh	—	—	187,151
2018-03-06	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+124K sh	—	—	123,750
2017-03-21	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−2,807 sh	$17.03	−$47.8K	166,526
2017-02-21	Adamas Pharmaceuticals IncA Award	Director, Chief Executive Officer	AAward	+23.1K sh	—	—	169,333
2017-02-21	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+139K sh	—	—	138,750
2016-10-05	Adamas Pharmaceuticals IncJ Other	Director, Chief Executive Officer	JOther	−117K sh	—	—	146,208
2016-10-05	Adamas Pharmaceuticals IncJ Other	Director, Chief Executive Officer	JOther	−195K sh	—	—	195,392
2016-10-05	Adamas Pharmaceuticals IncStock Option (Right to Buy)J Other	Director, Chief Executive Officer	JOther	−122K sh	—	—	128,216
2016-10-05	Adamas Pharmaceuticals IncStock Option (Right to Buy)J Other	Director, Chief Executive Officer	JOther	−28K sh	—	—	32,005
2016-10-05	Adamas Pharmaceuticals IncStock Option (Right to Buy)J Other	Director, Chief Executive Officer	JOther	−263K sh	—	—	605,037
2016-10-05	Adamas Pharmaceuticals IncStock Option (Right to Buy)J Other	Director, Chief Executive Officer	JOther	−9,439 sh	—	—	65,561
2016-06-15	Adamas Pharmaceuticals IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+205K sh	$1.88	+$384K	263,658
2016-06-15	Adamas Pharmaceuticals IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+205K sh	$1.88	+$384K	263,658
2016-06-15	Adamas Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−205K sh	—	—	0
2016-03-04	Adamas Pharmaceuticals IncA Award	Director, Chief Executive Officer	AAward	+28.8K sh	$13.66	+$393K	58,758
2016-03-04	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+173K sh	—	—	172,500
2015-05-14	Adamas Pharmaceuticals IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+100 sh	$1.88	+$187.5	30,108
2015-05-14	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−100 sh	$18.00	−$1,800	30,008
2015-05-14	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−200 sh	$18.00	−$3,600	390,792
2015-05-14	Adamas Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−100 sh	—	—	214,900
2015-05-13	Adamas Pharmaceuticals IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+10K sh	$1.88	+$18.8K	30,036
2015-05-13	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−28 sh	$18.00	−$504	30,008
2015-05-13	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−100 sh	$18.00	−$1,800	390,992
2015-05-13	Adamas Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−10K sh	—	—	215,000
2015-05-12	Adamas Pharmaceuticals IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+500 sh	$1.88	+$937.5	20,508
2015-05-12	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−500 sh	$18.01	−$9,003	20,008
2015-05-12	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−1,800 sh	$18.00	−$32.4K	391,092
2015-05-12	Adamas Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−500 sh	—	—	225,028
2015-04-23	Adamas Pharmaceuticals IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+900 sh	$1.88	+$1,687.5	20,908
2015-04-23	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−900 sh	$18.00	−$16.2K	20,008
2015-04-23	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−2,400 sh	$18.00	−$43.2K	392,892
2015-04-23	Adamas Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−900 sh	—	—	225,528
2015-04-21	Adamas Pharmaceuticals IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+962 sh	$1.88	+$1,803.75	20,970
2015-04-21	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−962 sh	$18.01	−$17.3K	20,008
2015-04-21	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−1,811 sh	$18.00	−$32.6K	395,292
2015-04-21	Adamas Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−962 sh	—	—	226,428
2015-04-20	Adamas Pharmaceuticals IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+2,610 sh	$1.88	+$4,893.75	22,618
2015-04-20	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−2,610 sh	$18.00	−$47K	20,008
2015-04-20	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−5,200 sh	$18.00	−$93.6K	397,103
2015-04-20	Adamas Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−2,610 sh	—	—	227,390
2015-04-14	Adamas Pharmaceuticals IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+80 sh	$1.88	+$150	10,088
2015-04-14	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−80 sh	$18.00	−$1,440	10,008
2015-04-14	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	+10K sh	$1.88	+$18.8K	20,008
2015-04-14	Adamas Pharmaceuticals IncS Sale	Director, Chief Executive Officer	SSale	−100 sh	$18.00	−$1,800	402,303
2015-04-14	Adamas Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−80 sh	—	—	230,000

Recent filings

Accepted (ET)
Apr 104
Went Gregory T0001209191-19-024248
SEC(opens sec.gov)
Mar 214
Went Gregory T0001209191-19-020763
SEC(opens sec.gov)
Nov 84
Went Gregory T0001209191-18-057797
SEC(opens sec.gov)
Mar 224
Went Gregory T0001209191-18-021318
SEC(opens sec.gov)
Mar 94
Went Gregory T0001209191-18-018677
SEC(opens sec.gov)
Mar 224
Adamas Pharmaceuticals Inc0001209191-17-022342
SEC(opens sec.gov)
Feb 234
Adamas Pharmaceuticals Inc0001209191-17-013940
SEC(opens sec.gov)
Feb 234/A
Adamas Pharmaceuticals Inc0001209191-17-013934
SEC(opens sec.gov)
Oct 74
Adamas Pharmaceuticals Inc0001209191-16-145419
SEC(opens sec.gov)
Jun 164
Adamas Pharmaceuticals Inc0001209191-16-128276
SEC(opens sec.gov)
Mar 84
Adamas Pharmaceuticals Inc0001209191-16-107117
SEC(opens sec.gov)

Companies

Adamas Pharmaceuticals IncDirector, Chief Executive Officer

Address

C/O ADAMAS PHARMACEUTICALS, INC. 2200 POWELL ST, STE 220

EMERYVILLE, CA, 94608